☰

fix formatting

Ryan Morin committed 2024-11-26 10:54:58 -0800 commit 4aee29e1e95ae94c2929a7694c3f2faff7e9bf71

				papers/russler-germainMutationsAssociatedProgression2023.md
			
          @@ -15,7 +15,7 @@ In their 2023 study published in *Blood Advances*, Russler-Germain et al. conduc

           - However, mutation burden was notably higher in relapsed/refractory FL and t-FL compared to newly diagnosed FL.

           ### Specific Gene Mutations

          -- **CREBBP** mutations were more prevalent in FL than in t-FL and were associated with shorter frontline progression-free survival (PFS) in FL patients.

          +- *CREBBP* mutations were more prevalent in FL than in t-FL and were associated with shorter frontline progression-free survival (PFS) in FL patients.

           - Mutations in *STAT6*, *TP53*, *IGLL5*, *B2M*, *SOCS1*, and *MYD88* were more common in relapsed/refractory FL or t-FL than in newly diagnosed FL.

           ### Mutations Associated with Progression (MAP) Signature

...	...	@@ -15,7 +15,7 @@ In their 2023 study published in Blood Advances, Russler-Germain et al. conduc
15	15	- However, mutation burden was notably higher in relapsed/refractory FL and t-FL compared to newly diagnosed FL.
16	16
17	17	### Specific Gene Mutations
18		-- CREBBP mutations were more prevalent in FL than in t-FL and were associated with shorter frontline progression-free survival (PFS) in FL patients.
	18	+- CREBBP mutations were more prevalent in FL than in t-FL and were associated with shorter frontline progression-free survival (PFS) in FL patients.
19	19	- Mutations in STAT6, TP53, IGLL5, B2M, SOCS1, and MYD88 were more common in relapsed/refractory FL or t-FL than in newly diagnosed FL.
20	20
21	21	### Mutations Associated with Progression (MAP) Signature